TNFRSF1A and myeloid sarcoma: In another study, [19] the impact of polymorphism A36G of the TNF-alpha receptor 1 (TNFRSF1A + 36A/G) on plasma concentrations of PAI-1 in 163 obese 31 with metabolic syndrome (MS) and 150 lean, healthy women was tested.